Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   33    
Direct Shares   1,028,565    

Indirect Shares

   243,774,473      
Direct Value   $73,841,312    

Indirect Value

   $16,621,918,985      
Total Shares   244,803,038      
Total Value   $16,695,760,297      


Incyte Corp $32,141,876 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,141,833 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,488,073 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $287,451 Incyte Corp $32,141,876 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,141,833 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,488,073 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $287,451
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2021-06-22 205,752 2021-06-22 38,452,877    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
* Premium Members only  

Records found :    496         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 13 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XOMA XOMA Corporation Director   –       •       •   2014-12-15 4 S $4.45 $2,050,652 I/I (460,800) 449,970 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-16 4 S $4.27 $1,363,271 I/I (319,200) 443,096 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-17 4 S $4.31 $2,958,129 I/I (686,500) 428,343 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-18 4 S $4.29 $710,687 I/I (165,700) 424,785 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-19 4 S $4.21 $3,168,580 I/I (752,900) 408,603 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-26 4 S $3.71 $486,460 I/I (131,100) 405,778 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-29 4 S $3.68 $812,440 I/I (221,000) 401,032 0 -
XOMA XOMA Corporation Director   –       •       •   2014-12-30 4 S $3.65 $1,430,239 I/I (391,900) 392,617 0 -
XOMA XOMA Corporation Director   –       •       •   2015-01-02 4 S $3.55 $753,740 I/I (212,100) 388,063 0 -
XOMA XOMA Corporation Director   –       •       •   2015-01-05 4 S $3.81 $3,824,078 I/I (1,003,300) 366,515 0 -
XOMA XOMA Corporation Director   –       •       •   2015-01-06 4 S $3.86 $3,860,000 I/I (1,000,000) 345,074 0 -
XOMA XOMA Corporation Former 10% owner   –       –      –    2015-07-22 4 S $1.09 $12,017,500 I/I (11,000,000) 90,538 0 -
NGNE Neurogene 10% Owner   –       –       •   2015-09-10 4 B $15.50 $38,440,496 I/I 2,480,032 6,022,104 1.5 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2016-01-07 4 B $29.00 $74,999,974 I/I 2,586,206 20,278,008 2.25 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-14 4 B $7.91 $959,882 I/I 117,953 6,128,358 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-15 4 B $8.10 $717,201 I/I 84,670 6,204,630 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-19 4 B $9.08 $711,115 I/I 78,045 6,274,969 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-20 4 B $8.90 $1,062,538 I/I 112,034 6,375,941 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-22 4 B $10.60 $559,810 I/I 52,202 6,422,989 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-25 4 B $10.98 $121,576 I/I 10,945 6,432,847 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-26 4 B $10.80 $839,524 I/I 77,639 6,502,773 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-03-15 4 B $7.88 $877,066 I/I 109,912 6,601,891 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-03-16 4 B $7.70 $2,893,570 I/I 361,755 6,928,119 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2016-09-20 4 B $12.25 $34,110,452 I/I 2,783,605 1,131,625 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2017-01-09 4 B $15.13 $6,836,813 I/I 398,062 9,764,459 1.5 -
  496  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13  14   15   16   17   18   19   20      
  Page 13 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us